spot_img
Thursday, June 30, 2022
No menu items!
More
    spot_img
    HomeBusinessDr. Reddy’s launches Nexavar generic in the US

    Dr. Reddy’s launches Nexavar generic in the US

    -

    News

    The drug is used to treat certain types of cancer

    Dr. Reddy’s Laboratories Ltd has launched sorafenib tablets, a therapeutic generic equivalent of Nexavar (sorafenib) in the US market following approval by the US Food and Drug Administration (USFDA). The drug is used to treat certain types of cancer. 

    “We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories Inc, said in a release. 

    The drug is available as 200 mg tablets in a bottle of 120.

    Published on June 14, 2022

    You May Also Like

    Recommended for you

    Related articles

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Stay Connected

    0FansLike
    0FollowersFollow
    3,370FollowersFollow
    0SubscribersSubscribe
    spot_img

    Latest posts